A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

February 28, 2026

Conditions
Relapsing Multiple Sclerosis
Interventions
DRUG

Obexelimab

Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcyRIIb, resulting in down regulation of B cell activity

DRUG

Placebo

Placebo

Trial Locations (47)

33620

University of South Florida, Tampa

35058

North Central Neurology, Cullman

35105

Aqualine Clinical Research, Naples

43235

Boster Center for MS, Columbus

53226

Medical College of Wisconsin, Milwaukee

53228

Center for Neurological Disorders, Greenfield

55446

Infusion Associates Plymouth, Plymouth

63131

MS Center for Innovations in Care, St Louis

75024

North Texas Institute of Neurology and Headache, Plano

85032

Center for Neurology and Spine, Phoenix

85253

Perseverance Research Center, Scottsdale

90048

Regina Berkovich MD PhD, Inc, West Hollywood

01655

University of Massachusetts Medical School, Worcester

07666

Holy Name Medical Center, Teaneck

Unknown

Neuro-logisch Wien, Vienna

Rehabilitation & MS Center, Noorderhart Hospital, Overpelt

AZ Delta-Deltalaan 1, Roeselare

Tiantan Hospital, Capital Medical University, Beijing

The First Affiliation Hospital of Soochow University, Suzhou

Tianjin Medical University General Hospital, Tianjin

People's Hospital of Xinjiang Uyaur Autonomous Region, Ürümqi

Tongji Hospital, Tongji Medical Center of HUST, Wuhan

Klinicki bolnicki centar Zagreb, Zagreb

Fakultni nemocnice u sv. Anny v Brne, Brno

Nemocnice Jihlava, Jihlava

General University Hospital Praha, Prague

Aalborg Universitetshospital, Aalborg

Attikon University General Hospital, Chaïdári

University General Hospital of Larissa, Larissa

Fondazione Isituto G. Giglio di Cefalu, Cefalù

University of Florence, Florence

Istituto Neurologico Mediterraneo Neuromed, Pozzilli

Fondazione PTV Policlinico Tor Vergata, Roma

Neurocentrum Bydgoszcz sp.z o.o., Bydgoszcz

M.A. LEK A.M. Maciejowsy Spolka Cywilna, Katowice

Zanamed Medical Clinic Sp z o.o., Lublin

Wielospecjalistyczne Centrum Medyczne Ibismed, Zabrze

Hospital Clinico San Carlos, Madrid

Hospital General Universitario Gregorio Marañon, Madrid

Hospital Regional Universitario de Malaga - Hospital General, Málaga

Hospital Regional Universitario de Malaga, Málaga

Hospital Universitario Virgen de La Arrixaca, Murcia

Hospital Virgen Macarena, Seville

Hospipal La Fe Valencia, Valencia

Leicester General Hospital, Leicester

Barts Health NHS Trust, London

Morriston Hospital, Swansea

All Listed Sponsors
lead

Zenas BioPharma (USA), LLC

INDUSTRY

NCT06564311 - A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) | Biotech Hunter | Biotech Hunter